{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:39:51Z","timestamp":1790822391586,"version":"4.1.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Novo Nordisk Foundation Initiative on Vaccines and Immunity (NIVI) that is supported by the Novo Nordisk Foundation","award":["NNF23SA0088562"],"award-info":[{"award-number":["NNF23SA0088562"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01387-y","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:25:51Z","timestamp":1775319951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mycobacterium tuberculosis bacteriology and immunity necessitate a multi-pronged immune strategy for vaccination"],"prefix":"10.1038","volume":"11","author":[{"given":"Jan T.","family":"Poolman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"1387_CR1","unstructured":"World Health Organization. Tuberculosis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis (2025)."},{"key":"1387_CR2","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(24)02479-6","volume":"405","author":"A Trajman","year":"2025","unstructured":"Trajman, A. et al. Tuberculosis. Lancet 405, 850\u2013866 (2025).","journal-title":"Lancet"},{"key":"1387_CR3","unstructured":"World Health Organization. Global tuberculosis report https:\/\/iris.who.int\/bitstream\/handle\/10665\/379339\/9789240101531-eng.pdf?sequence=1 2024."},{"key":"1387_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","volume":"58","author":"P Mangtani","year":"2014","unstructured":"Mangtani, P. et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin. Infect. Dis. 58, 470\u2013480 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"1387_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55501-6","volume":"16","author":"TP Setiabudiawan","year":"2025","unstructured":"Setiabudiawan, T. P. et al. Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia. Nat. Commun. 16, 309 (2025).","journal-title":"Nat. Commun."},{"key":"1387_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01107-x","volume":"12","author":"N Salari","year":"2023","unstructured":"Salari, N. et al. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect. Dis. Poverty 12, 57 (2023).","journal-title":"Infect. Dis. Poverty"},{"key":"1387_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.943545","volume":"12","author":"D Liebenberg","year":"2022","unstructured":"Liebenberg, D., Gordhan, B. G. & Kana, B. D. Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management. Front. Cell. Infect. Microbiol. 12, 943545. https:\/\/doi.org\/10.3389\/fcimb.2022.943545 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1387_CR8","unstructured":"World Health Organization. The End TB strategy. https:\/\/iris.who.int\/bitstream\/handle\/10665\/331326\/WHO-HTM-TB-2015.19-eng.pdf?sequence=1 (2015)."},{"key":"1387_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.cell.2014.11.024","volume":"159","author":"CJ Cambier","year":"2014","unstructured":"Cambier, C. J., Falkow, S. & Ramakrishnan, L. Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell 159, 1497\u20131509 (2014).","journal-title":"Cell"},{"key":"1387_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34853-x","volume":"13","author":"P Chitale","year":"2022","unstructured":"Chitale, P. et al. A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome. Nat. Commun. 13, 7068 (2022).","journal-title":"Nat. Commun."},{"key":"1387_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","volume":"393","author":"ST Cole","year":"1998","unstructured":"Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537\u2013544 (1998).","journal-title":"Nature"},{"key":"1387_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152321","volume":"228","author":"C D\u2019Souza","year":"2023","unstructured":"D\u2019Souza, C., Kishore, U. & Tsolaki, A. G. The PE-PPE family of Mycobacterium tuberculosis: proteins in disguise. Immunobiology 228, 152321. https:\/\/doi.org\/10.1016\/j.imbio.2022.152321 (2023).","journal-title":"Immunobiology"},{"key":"1387_CR13","doi-asserted-by":"publisher","unstructured":"Ly, A. & Liu, J. Mycobacterial virulence factors: surface-exposed lipids and secreted proteins. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21113985 (2020).","DOI":"10.3390\/ijms21113985"},{"key":"1387_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.594288","volume":"10","author":"J Qian","year":"2020","unstructured":"Qian, J., Chen, R., Wang, H. & Zhang, X. Role of the PE\/PPE family in host-pathogen interactions and prospects for anti-tuberculosis vaccine and diagnostic tool design. Front. Cell. Infect. Microbiol. 10, 594288. https:\/\/doi.org\/10.3389\/fcimb.2020.594288 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1387_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tim.2024.10.007","volume":"33","author":"PR Singh","year":"2025","unstructured":"Singh, P. R. & Nagaraja, V. Epigenetic maneuvering: an emerging strategy for mycobacterial intracellular survival. Trends Microbiol. 33, 354\u2013369 (2025).","journal-title":"Trends Microbiol."},{"key":"1387_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","volume":"16","author":"I Smith","year":"2003","unstructured":"Smith, I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev. 16, 463\u2013496 (2003).","journal-title":"Clin. Microbiol. Rev."},{"key":"1387_CR17","doi-asserted-by":"publisher","first-page":"e1012956","DOI":"10.1371\/journal.ppat.1012956","volume":"21","author":"MI Sweeney","year":"2025","unstructured":"Sweeney, M. I., Carranza, C. E. & Tobin, D. M. Understanding Mycobacterium tuberculosis through its genomic diversity and evolution. PLoS Pathog. 21, e1012956 (2025).","journal-title":"PLoS Pathog."},{"key":"1387_CR18","doi-asserted-by":"publisher","unstructured":"Daffe, M. & Marrakchi, H. Unraveling the structure of the mycobacterial envelope. Microbiol. Spectrum 7 https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0027-2018 (2019).","DOI":"10.1128\/microbiolspec.GPP3-0027-2018"},{"key":"1387_CR19","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.3389\/fimmu.2019.02909","volume":"10","author":"A Garcia-Vilanova","year":"2019","unstructured":"Garcia-Vilanova, A., Chan, J. & Torrelles, J. B. Underestimated manipulative roles of Mycobacterium tuberculosis cell envelope glycolipids during infection. Front. Immunol. 10, 2909 (2019).","journal-title":"Front. Immunol."},{"key":"1387_CR20","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/j.1462-5822.2007.00940.x","volume":"9","author":"MC Gagliardi","year":"2007","unstructured":"Gagliardi, M. C. et al. Cell wall-associated alpha-glucan is instrumental for Mycobacterium tuberculosis to block CD1 molecule expression and disable the function of dendritic cell derived from infected monocyte. Cell. Microbiol. 9, 2081\u20132092 (2007).","journal-title":"Cell. Microbiol."},{"key":"1387_CR21","doi-asserted-by":"publisher","first-page":"e1005768","DOI":"10.1371\/journal.ppat.1005768","volume":"12","author":"H Koliwer-Brandl","year":"2016","unstructured":"Koliwer-Brandl, H. et al. Metabolic network for the biosynthesis of intra- and extracellular alpha-glucans required for virulence of Mycobacterium tuberculosis. PLoS Pathog. 12, e1005768 (2016).","journal-title":"PLoS Pathog."},{"key":"1387_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1074\/jbc.M114.589200","volume":"290","author":"HK Dkhar","year":"2015","unstructured":"Dkhar, H. K. et al. Discovery of Mycobacterium tuberculosis alpha-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening. J. Biol. Chem. 290, 76\u201389 (2015).","journal-title":"J. Biol. Chem."},{"key":"1387_CR23","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1042\/BCJ20190324","volume":"476","author":"R Kalscheuer","year":"2019","unstructured":"Kalscheuer, R. et al. The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis. Biochem. J. 476, 1995\u20132016 (2019).","journal-title":"Biochem. J."},{"key":"1387_CR24","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1111\/febs.16369","volume":"289","author":"R Pal","year":"2022","unstructured":"Pal, R., Bisht, M. K. & Mukhopadhyay, S. Secretory proteins of Mycobacterium tuberculosis and their roles in modulation of host immune responses: focus on therapeutic targets. FEBS J. 289, 4146\u20134171 (2022).","journal-title":"FEBS J."},{"key":"1387_CR25","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1128\/IAI.01022-06","volume":"74","author":"S Kurtz","year":"2006","unstructured":"Kurtz, S., McKinnon, K. P., Runge, M. S., Ting, J. P. & Braunstein, M. The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response. Infect. Immun. 74, 6855\u20136864 (2006).","journal-title":"Infect. Immun."},{"key":"1387_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20533-1","volume":"12","author":"U Tak","year":"2021","unstructured":"Tak, U., Dokland, T. & Niederweis, M. Pore-forming Esx proteins mediate toxin secretion by Mycobacterium tuberculosis. Nat. Commun. 12, 394 (2021).","journal-title":"Nat. Commun."},{"key":"1387_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-micro-012420-081657","volume":"74","author":"CM Bunduc","year":"2020","unstructured":"Bunduc, C. M., Bitter, W. & Houben, E. N. G. Structure and function of the mycobacterial type VII secretion systems. Annu. Rev. Microbiol. 74, 315\u2013335 (2020).","journal-title":"Annu. Rev. Microbiol."},{"key":"1387_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biochi.2023.10.013","volume":"216","author":"AL Granados-Tristan","year":"2024","unstructured":"Granados-Tristan, A. L. et al. ESX-3 secretion system in Mycobacterium: an overview. Biochimie 216, 46\u201355 (2024).","journal-title":"Biochimie"},{"key":"1387_CR29","doi-asserted-by":"publisher","first-page":"e1010610","DOI":"10.1371\/journal.ppat.1010610","volume":"18","author":"KR Nicholson","year":"2022","unstructured":"Nicholson, K. R. & Champion, P. A. Bacterial secretion systems: networks of pathogenic regulation and adaptation in mycobacteria and beyond. PLoS Pathog. 18, e1010610 (2022).","journal-title":"PLoS Pathog."},{"key":"1387_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00402-23","volume":"8","author":"CM Bunduc","year":"2023","unstructured":"Bunduc, C. M. et al. Reconstitution of a minimal ESX-5 type VII secretion system suggests a role for PPE proteins in the outer membrane transport of proteins. mSphere 8, e0040223. https:\/\/doi.org\/10.1128\/msphere.00402-23 (2023).","journal-title":"mSphere"},{"issue":"11","key":"1387_CR31","first-page":"648440","volume":"04","author":"B Koleske","year":"2025","unstructured":"Koleske, B. et al. Loss of the ESX-5 secretion locus in Mycobacterium tuberculosis reshapes the mycomembrane and enhances ESX-1 substrate secretion. bioRxiv 04(11), 648440 (2025).","journal-title":"bioRxiv"},{"key":"1387_CR32","doi-asserted-by":"publisher","first-page":"e1004446","DOI":"10.1371\/journal.ppat.1004446","volume":"10","author":"G Sreejit","year":"2014","unstructured":"Sreejit, G. et al. The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (beta2M) affecting antigen presentation function of macrophage. PLoS Pathog. 10, e1004446 (2014).","journal-title":"PLoS Pathog."},{"key":"1387_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2019.126392","volume":"232","author":"V Vinod","year":"2020","unstructured":"Vinod, V., Vijayrajratnam, S., Vasudevan, A. K. & Biswas, R. The cell surface adhesins of Mycobacterium tuberculosis. Microbiol. Res. 232, 126392. https:\/\/doi.org\/10.1016\/j.micres.2019.126392 (2020).","journal-title":"Microbiol. Res."},{"key":"1387_CR34","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.4049\/jimmunol.1000773","volume":"186","author":"S Nair","year":"2011","unstructured":"Nair, S., Pandey, A. D. & Mukhopadhyay, S. The PPE18 protein of Mycobacterium tuberculosis inhibits NF-kappaB\/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein. J. Immunol. 186, 5413\u20135424 (2011).","journal-title":"J. Immunol."},{"key":"1387_CR35","doi-asserted-by":"publisher","unstructured":"Mehta, V. et al. Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane adenylyl cyclases. eLife 11 (2022). https:\/\/doi.org\/10.7554\/eLife.77032","DOI":"10.7554\/eLife.77032"},{"key":"1387_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4103\/ijmy.ijmy_190_23","volume":"12","author":"P Farnia","year":"2023","unstructured":"Farnia, P. et al. Identification of seven types of pili in Mycobacterium tuberculosis: Using atomic force microscopy. Int. J. Mycobacteriol 12, 478\u2013485 (2023).","journal-title":"Int. J. Mycobacteriol"},{"key":"1387_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.916247","volume":"12","author":"CJ Alteri","year":"2022","unstructured":"Alteri, C. J. et al. The Flp type IV pilus operon of Mycobacterium tuberculosis is expressed upon interaction with macrophages and alveolar epithelial cells. Front. Cell. Infect. Microbiol. 12, 916247. https:\/\/doi.org\/10.3389\/fcimb.2022.916247 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1387_CR38","unstructured":"Alteri, C. Novel pili of Mycobacterium tuberculosis PhD thesis (The University of Arizona, 2005)."},{"key":"1387_CR39","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1073\/pnas.0602304104","volume":"104","author":"CJ Alteri","year":"2007","unstructured":"Alteri, C. J. et al. Mycobacterium tuberculosis produces pili during human infection. Proc. Natl. Acad. Sci. USA 104, 5145\u20135150 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1387_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-025-02320-5","volume":"21","author":"TJ Naidoo","year":"2025","unstructured":"Naidoo, T. J. et al. Mycobacterium tuberculosis curli pili facilitates pathogenicity by modulating central carbon metabolism. Metabolomics 21, 118 (2025).","journal-title":"Metabolomics"},{"key":"1387_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111063","volume":"27","author":"AM Barclay","year":"2024","unstructured":"Barclay, A. M. et al. Mycobacteria develop biofilms on airway epithelial cells and promote mucosal barrier disruption. iScience 27, 111063. https:\/\/doi.org\/10.1016\/j.isci.2024.111063 (2024).","journal-title":"iScience"},{"key":"1387_CR42","doi-asserted-by":"publisher","unstructured":"Richards, J. P., Cai, W., Zill, N. A., Zhang, W. & Ojha, A. K. Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance. Antimicrob. Agents Chemother. 63 https:\/\/doi.org\/10.1128\/AAC.01213-19 (2019).","DOI":"10.1128\/AAC.01213-19"},{"key":"1387_CR43","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1016\/j.cell.2023.09.016","volume":"186","author":"R Mishra","year":"2023","unstructured":"Mishra, R. et al. Mechanopathology of biofilm-like Mycobacterium tuberculosis cords. Cell 186, 5135\u20135150 e5128 (2023).","journal-title":"Cell"},{"key":"1387_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.876667","volume":"12","author":"GM Rodriguez","year":"2022","unstructured":"Rodriguez, G. M., Sharma, N., Biswas, A. & Sharma, N. The iron response of Mycobacterium tuberculosis and its implications for tuberculosis pathogenesis and novel therapeutics. Front. Cell. Infect. Microbiol. 12, 876667. https:\/\/doi.org\/10.3389\/fcimb.2022.876667 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1387_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1360880","volume":"14","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. The role of transcriptional regulators in metal ion homeostasis of Mycobacterium tuberculosis. Front. Cell. Infect. Microbiol. 14, 1360880. https:\/\/doi.org\/10.3389\/fcimb.2024.1360880 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1387_CR46","doi-asserted-by":"publisher","unstructured":"Mehdiratta, K. et al. Kupyaphores are zinc homeostatic metallophores required for colonization of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 119 https:\/\/doi.org\/10.1073\/pnas.2110293119 (2022).","DOI":"10.1073\/pnas.2110293119"},{"key":"1387_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2150449","volume":"14","author":"KC Rahlwes","year":"2023","unstructured":"Rahlwes, K. C., Dias, B. R. S., Campos, P. C., Alvarez-Arguedas, S. & Shiloh, M. U. Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence 14, 2150449. https:\/\/doi.org\/10.1080\/21505594.2022.2150449 (2023).","journal-title":"Virulence"},{"key":"1387_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","volume":"18","author":"JD Simmons","year":"2018","unstructured":"Simmons, J. D. et al. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat. Rev. Immunol. 18, 575\u2013589 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1387_CR49","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/imm.12223","volume":"141","author":"AJ Verrall","year":"2014","unstructured":"Verrall, A. J., Netea, M. G., Alisjahbana, B., Hill, P. C. & van Crevel, R. Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology 141, 506\u2013513 (2014).","journal-title":"Immunology"},{"key":"1387_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.747799","volume":"13","author":"F Ahmad","year":"2022","unstructured":"Ahmad, F. et al. Macrophage: a cell with many faces and functions in tuberculosis. Front. Immunol. 13, 747799. https:\/\/doi.org\/10.3389\/fimmu.2022.747799 (2022).","journal-title":"Front. Immunol."},{"key":"1387_CR51","doi-asserted-by":"publisher","unstructured":"Yabaji, S. M. et al. Aberrant macrophage activation and maladaptive lung repair promote tuberculosis progression uniquely in the lung. bioRxiv https:\/\/doi.org\/10.1101\/2023.10.17.562695 (2025).","DOI":"10.1101\/2023.10.17.562695"},{"key":"1387_CR52","doi-asserted-by":"publisher","unstructured":"Zilinskas, A. et al. Mycobacterium tuberculosis suppresses protective Th17 responses during infection through multiple mechanisms. bioRxiv https:\/\/doi.org\/10.1101\/2025.05.08.652811 (2025).","DOI":"10.1101\/2025.05.08.652811"},{"key":"1387_CR53","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41590-024-01897-8","volume":"25","author":"M Sun","year":"2024","unstructured":"Sun, M. et al. Specific CD4(+) T cell phenotypes associate with bacterial control in people who \u2018resist\u2019 infection with Mycobacterium tuberculosis. Nat. Immunol. 25, 1411\u20131421 (2024).","journal-title":"Nat. Immunol."},{"key":"1387_CR54","doi-asserted-by":"publisher","unstructured":"Becker, S. H., Ronayne, C. E., Bold, T. D. & Jenkins, M. K. CD4 (+) T cells recruit, then engage macrophages in cognate interactions to clear Mycobacterium tuberculosis from the lungs. bioRxiv https:\/\/doi.org\/10.1101\/2024.08.22.609198 (2024).","DOI":"10.1101\/2024.08.22.609198"},{"key":"1387_CR55","doi-asserted-by":"publisher","unstructured":"Ogongo, P. et al. Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infection. bioRxiv https:\/\/doi.org\/10.1101\/2024.03.05.583634 (2024).","DOI":"10.1101\/2024.03.05.583634"},{"key":"1387_CR56","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","volume":"188","author":"CL Day","year":"2013","unstructured":"Day, C. L. et al. Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72\/AS01 in South African adults. Am. J. Respir. Crit. Care Med. 188, 492\u2013502 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1387_CR57","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","volume":"381","author":"DR Tait","year":"2019","unstructured":"Tait, D. R. et al. Final analysis of a trial of M72\/AS01(E) vaccine to prevent tuberculosis. N. Engl. J. Med. 381, 2429\u20132439 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1387_CR58","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","volume":"379","author":"O Van Der Meeren","year":"2018","unstructured":"Van Der Meeren, O. et al. Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis. N. Engl. J. Med. 379, 1621\u20131634 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1387_CR59","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0140-6736(24)00579-8","volume":"403","author":"T Burki","year":"2024","unstructured":"Burki, T. Pivotal tuberculosis vaccine trial begins. Lancet 403, 1125 (2024).","journal-title":"Lancet"},{"key":"1387_CR60","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","volume":"31","author":"I Leroux-Roels","year":"2013","unstructured":"Leroux-Roels, I. et al. Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial. Vaccine 31, 2196\u20132206 (2013).","journal-title":"Vaccine"},{"key":"1387_CR61","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s10875-013-9949-3","volume":"33","author":"J Montoya","year":"2013","unstructured":"Montoya, J. et al. A randomized, controlled dose-finding Phase II study of the M72\/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults. J. Clin. Immunol. 33, 1360\u20131375 (2013).","journal-title":"J. Clin. Immunol."},{"key":"1387_CR62","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fimmu.2018.00564","volume":"9","author":"RA van den Berg","year":"2018","unstructured":"van den Berg, R. A. et al. Adjuvant-associated peripheral blood mRNA profiles and kinetics induced by the adjuvanted recombinant protein candidate tuberculosis vaccine M72\/AS01 in Bacillus Calmette-Guerin-vaccinated adults. Front. Immunol. 9, 564 (2018).","journal-title":"Front. Immunol."},{"key":"1387_CR63","doi-asserted-by":"publisher","first-page":"e1007643","DOI":"10.1371\/journal.ppat.1007643","volume":"15","author":"MJ Rodo","year":"2019","unstructured":"Rodo, M. J. et al. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates. PLoS Pathog. 15, e1007643 (2019).","journal-title":"PLoS Pathog."},{"key":"1387_CR64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes, E. et al. Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination. N. Engl. J. Med. 379, 138\u2013149 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1387_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49050-1","volume":"15","author":"OB Dintwe","year":"2024","unstructured":"Dintwe, O. B. et al. Adolescent BCG revaccination induces a phenotypic shift in CD4(+) T cell responses to Mycobacterium tuberculosis. Nat. Commun. 15, 5191 (2024).","journal-title":"Nat. Commun."},{"key":"1387_CR66","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMoa2412381","volume":"392","author":"AC Schmidt","year":"2025","unstructured":"Schmidt, A. C. et al. BCG revaccination for the prevention of Mycobacterium tuberculosis infection. N. Engl. J. Med. 392, 1789\u20131800 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1387_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.619988","volume":"12","author":"J Gutierrez","year":"2021","unstructured":"Gutierrez, J., Kroon, E. E., Moller, M. & Stein, C. M. Phenotype definition for \u201cResisters\u201d to Mycobacterium tuberculosis infection in the literature-a review and recommendations. Front. Immunol. 12, 619988. https:\/\/doi.org\/10.3389\/fimmu.2021.619988 (2021).","journal-title":"Front. Immunol."},{"key":"1387_CR68","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/cid\/ciab269","volume":"73","author":"D Baliashvili","year":"2021","unstructured":"Baliashvili, D. et al. Resistance to Mycobacterium tuberculosis infection among household contacts: a multinational study. Clin. Infect. Dis. 73, 1037\u20131045 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1387_CR69","doi-asserted-by":"publisher","unstructured":"Cross, D. L. et al. MR1-restricted T cell clonotypes are associated with \u201cresistance\u201d to Mycobacterium tuberculosis infection. JCI Insight 9 https:\/\/doi.org\/10.1172\/jci.insight.166505 (2024).","DOI":"10.1172\/jci.insight.166505"},{"key":"1387_CR70","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","volume":"25","author":"LL Lu","year":"2019","unstructured":"Lu, L. L. et al. IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure. Nat. Med. 25, 977\u2013987 (2019).","journal-title":"Nat. Med."},{"key":"1387_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104678","volume":"93","author":"LRL Davies","year":"2023","unstructured":"Davies, L. R. L. et al. IFN-gamma independent markers of Mycobacterium tuberculosis exposure among male South African gold miners. EBioMedicine 93, 104678. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104678 (2023).","journal-title":"EBioMedicine"},{"key":"1387_CR72","doi-asserted-by":"publisher","unstructured":"Dallmann-Sauer, M. et al. Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli. J. Clin. Invest. 135 https:\/\/doi.org\/10.1172\/JCI188016 (2025).","DOI":"10.1172\/JCI188016"},{"key":"1387_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye, S. G. et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol. 40, 24\u201364 (2020).","journal-title":"J. Clin. Immunol."},{"key":"1387_CR74","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.coi.2021.07.001","volume":"72","author":"S Boisson-Dupuis","year":"2021","unstructured":"Boisson-Dupuis, S. & Bustamante, J. Mycobacterial diseases in patients with inborn errors of immunity. Curr. Opin. Immunol. 72, 262\u2013271 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"1387_CR75","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","volume":"139","author":"J Bustamante","year":"2020","unstructured":"Bustamante, J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum. Genet. 139, 993\u20131000 (2020).","journal-title":"Hum. Genet."},{"key":"1387_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","volume":"15","author":"S Minozzi","year":"2016","unstructured":"Minozzi, S. et al. Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin. Drug Saf. 15, 11\u201334 (2016).","journal-title":"Expert Opin. Drug Saf."},{"key":"1387_CR77","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s11033-011-1110-x","volume":"39","author":"Q Wang","year":"2012","unstructured":"Wang, Q., Zhan, P., Qiu, L. X., Qian, Q. & Yu, L. K. TNF-308 gene polymorphism and tuberculosis susceptibility: a meta-analysis involving 18 studies. Mol. Biol. Rep. 39, 3393\u20133400 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"1387_CR78","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.4238\/2015.July.31.8","volume":"14","author":"YH Lee","year":"2015","unstructured":"Lee, Y. H. & Song, G. G. Associations between tumor necrosis factor-alpha polymorphisms and susceptibility to pulmonary tuberculosis: meta-analysis. Genet Mol. Res 14, 8602\u20138612 (2015).","journal-title":"Genet Mol. Res"},{"key":"1387_CR79","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-024-07866-3","volume":"633","author":"AA Arias","year":"2024","unstructured":"Arias, A. A. et al. Tuberculosis in otherwise healthy adults with inherited TNF deficiency. Nature 633, 417\u2013425 (2024).","journal-title":"Nature"},{"key":"1387_CR80","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e4","volume":"24","author":"JM Yuk","year":"2024","unstructured":"Yuk, J. M., Kim, J. K., Kim, I. S. & Jo, E. K. TNF in human tuberculosis: a double-edged sword. Immune Netw. 24, e4. https:\/\/doi.org\/10.4110\/in.2024.24.e4 (2024).","journal-title":"Immune Netw."},{"key":"1387_CR81","doi-asserted-by":"publisher","unstructured":"Olsen, A. et al. Targeting Mycobacterium tuberculosis tumor necrosis factor alpha-downregulating genes for the development of antituberculous vaccines. mBio 7 https:\/\/doi.org\/10.1128\/mBio.01023-15 (2016).","DOI":"10.1128\/mBio.01023-15"},{"key":"1387_CR82","doi-asserted-by":"publisher","first-page":"E8277","DOI":"10.1073\/pnas.1618300114","volume":"113","author":"R Levy","year":"2016","unstructured":"Levy, R. et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc. Natl. Acad. Sci. USA 113, E8277\u2013E8285 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1387_CR83","doi-asserted-by":"publisher","unstructured":"Veerapandian, R., Gadad, S. S., Jagannath, C. & Dhandayuthapani, S. Live attenuated vaccines against tuberculosis: targeting the disruption of genes encoding the secretory proteins of mycobacteria. Vaccines 12 https:\/\/doi.org\/10.3390\/vaccines12050530 (2024).","DOI":"10.3390\/vaccines12050530"},{"key":"1387_CR84","unstructured":"Ates, L. Preclinical development of mRNA-based tuberculosis vaccines \u2013 How BNT164 applies learnings from Comirnaty\u00ae. Presented at the TBVI Symposium January 28-29, https:\/\/tbvi.eu\/les-diablerets-2025-presentations-are-now-available\/ 2025."},{"key":"1387_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.994247","volume":"13","author":"HM Li","year":"2022","unstructured":"Li, H. M., Wang, L. J., Huang, Q., Pan, H. F. & Zhang, T. P. Exploring the association between Th17 pathway gene polymorphisms and pulmonary tuberculosis. Front. Immunol. 13, 994247. https:\/\/doi.org\/10.3389\/fimmu.2022.994247 (2022).","journal-title":"Front. Immunol."},{"key":"1387_CR86","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1016\/j.cell.2022.10.025","volume":"185","author":"JL Flynn","year":"2022","unstructured":"Flynn, J. L. & Chan, J. Immune cell interactions in tuberculosis. Cell 185, 4682\u20134702 (2022).","journal-title":"Cell"},{"key":"1387_CR87","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/854507","volume":"2015","author":"IV Lyadova","year":"2015","unstructured":"Lyadova, I. V. & Panteleev, A. V. Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers. Mediators Inflamm. 2015, 854507. https:\/\/doi.org\/10.1155\/2015\/854507 (2015).","journal-title":"Mediators Inflamm."},{"key":"1387_CR88","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cmi.2017.128","volume":"15","author":"H Shen","year":"2018","unstructured":"Shen, H. & Chen, Z. W. The crucial roles of Th17-related cytokines\/signal pathways in M. tuberculosis infection. Cell. Mol. Immunol. 15, 216\u2013225 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"1387_CR89","doi-asserted-by":"publisher","unstructured":"Weth, A. F., Dangerfield, E. M., Timmer, M. S. M. & Stocker, B. L. Recent advances in the development of mincle-targeting vaccine adjuvants. Vaccines 12 https:\/\/doi.org\/10.3390\/vaccines12121320 (2024).","DOI":"10.3390\/vaccines12121320"},{"key":"1387_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00897-x","volume":"9","author":"V Rungelrath","year":"2024","unstructured":"Rungelrath, V. et al. Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. NPJ Vaccines 9, 100 (2024).","journal-title":"NPJ Vaccines"},{"key":"1387_CR91","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1021\/acsabm.4c00245","volume":"7","author":"WM Abdelwahab","year":"2024","unstructured":"Abdelwahab, W. M. et al. Promotion of Th17 polarized immunity via co-delivery of mincle agonist and tuberculosis antigen using silica nanoparticles. ACS Appl Bio Mater. 7, 3877\u20133889 (2024).","journal-title":"ACS Appl Bio Mater."},{"key":"1387_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52863-9","volume":"15","author":"JS Woodworth","year":"2024","unstructured":"Woodworth, J. S. et al. MINCLE and TLR9 agonists synergize to induce Th1\/Th17 vaccine memory and mucosal recall in mice and non-human primates. Nat. Commun. 15, 8959 (2024).","journal-title":"Nat. Commun."},{"key":"1387_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26934-0","volume":"12","author":"JS Woodworth","year":"2021","unstructured":"Woodworth, J. S. et al. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin. Nat. Commun. 12, 6658 (2021).","journal-title":"Nat. Commun."},{"key":"1387_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00666-2","volume":"8","author":"K Dijkman","year":"2023","unstructured":"Dijkman, K. et al. A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG. NPJ Vaccines 8, 66 (2023).","journal-title":"NPJ Vaccines"},{"key":"1387_CR95","doi-asserted-by":"publisher","unstructured":"Ogongo, P. et al. Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung. J. Clin. Invest. 131 https:\/\/doi.org\/10.1172\/JCI142014 (2021).","DOI":"10.1172\/JCI142014"},{"key":"1387_CR96","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41577-023-00853-1","volume":"23","author":"E Rotrosen","year":"2023","unstructured":"Rotrosen, E. & Kupper, T. S. Assessing the generation of tissue resident memory T cells by vaccines. Nat. Rev. Immunol. 23, 655\u2013665 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1387_CR97","doi-asserted-by":"publisher","unstructured":"Winchell, C. G. et al. CD8+ lymphocytes are critical for early control of tuberculosis in macaques. J. Exp. Med. 220 https:\/\/doi.org\/10.1084\/jem.20230707 (2023).","DOI":"10.1084\/jem.20230707"},{"key":"1387_CR98","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1586\/14760584.6.3.441","volume":"6","author":"SM Behar","year":"2007","unstructured":"Behar, S. M., Woodworth, J. S. & Wu, Y. Next generation: tuberculosis vaccines that elicit protective CD8+ T cells. Expert Rev. Vaccines 6, 441\u2013456 (2007).","journal-title":"Expert Rev. Vaccines"},{"key":"1387_CR99","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn, J. L. et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249\u20132254 (1993).","journal-title":"J. Exp. Med."},{"key":"1387_CR100","doi-asserted-by":"publisher","unstructured":"Miranda-Hernandez, S. et al. CD8 (+) T cells mediate vaccination-induced lymphatic containment of latent Mycobacterium tuberculosis infection following immunosuppression, while B cells are dispensable. bioRxiv https:\/\/doi.org\/10.1101\/2025.01.23.634479 (2025).","DOI":"10.1101\/2025.01.23.634479"},{"key":"1387_CR101","doi-asserted-by":"publisher","first-page":"e67016","DOI":"10.1371\/journal.pone.0067016","volume":"8","author":"DM Lewinsohn","year":"2013","unstructured":"Lewinsohn, D. M. et al. Human Mycobacterium tuberculosis CD8 T Cell antigens\/epitopes identified by a proteomic peptide library. PLoS One 8, e67016 (2013).","journal-title":"PLoS One"},{"key":"1387_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112911","volume":"42","author":"DL Ivanova","year":"2023","unstructured":"Ivanova, D. L. et al. Vaccine adjuvant-elicited CD8(+) T cell immunity is co-dependent on T-bet and FOXO1. Cell Rep. 42, 112911. https:\/\/doi.org\/10.1016\/j.celrep.2023.112911 (2023).","journal-title":"Cell Rep."},{"key":"1387_CR103","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.vaccine.2019.10.102","volume":"38","author":"M Wilkie","year":"2020","unstructured":"Wilkie, M. et al. A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults. Vaccine 38, 779\u2013789 (2020).","journal-title":"Vaccine"},{"key":"1387_CR104","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","volume":"381","author":"MD Tameris","year":"2013","unstructured":"Tameris, M. D. et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381, 1021\u20131028 (2013).","journal-title":"Lancet"},{"key":"1387_CR105","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41563-022-01464-2","volume":"22","author":"Q Yin","year":"2023","unstructured":"Yin, Q. et al. A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2. Nat. Mater. 22, 380\u2013390, https:\/\/doi.org\/10.1038\/s41563-022-01464-2 (2023).","journal-title":"Nat. Mater."},{"key":"1387_CR106","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fimmu.2016.00594","volume":"7","author":"S Huang","year":"2016","unstructured":"Huang, S. Targeting innate-like T cells in tuberculosis. Front. Immunol. 7, 594 (2016).","journal-title":"Front. Immunol."},{"key":"1387_CR107","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","volume":"37","author":"PL Lin","year":"2015","unstructured":"Lin, P. L. & Flynn, J. L. CD8 T cells and Mycobacterium tuberculosis infection. Semin. Immunopathol. 37, 239\u2013249 (2015).","journal-title":"Semin. Immunopathol."},{"key":"1387_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade3525","volume":"8","author":"R Roy Chowdhury","year":"2023","unstructured":"Roy Chowdhury, R. et al. NK-like CD8(+) gammadelta T cells are expanded in persistent Mycobacterium tuberculosis infection. Sci. Immunol. 8, eade3525. https:\/\/doi.org\/10.1126\/sciimmunol.ade3525 (2023).","journal-title":"Sci. Immunol."},{"key":"1387_CR109","doi-asserted-by":"publisher","unstructured":"Sakai, Y. et al. A conserved human CD4+ T cell subset recognizing the mycobacterial adjuvant trehalose monomycolate. J. Clin. Invest. 135 https:\/\/doi.org\/10.1172\/JCI185443 (2024).","DOI":"10.1172\/JCI185443"},{"key":"1387_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107511","volume":"300","author":"TP Cao","year":"2024","unstructured":"Cao, T. P. et al. A structural perspective of how T cell receptors recognize the CD1 family of lipid antigen-presenting molecules. J. Biol. Chem. 300, 107511. https:\/\/doi.org\/10.1016\/j.jbc.2024.107511 (2024).","journal-title":"J. Biol. Chem."},{"key":"1387_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13257","volume":"7","author":"S Gras","year":"2016","unstructured":"Gras, S. et al. T cell receptor recognition of CD1b presenting a mycobacterial glycolipid. Nat. Commun. 7, 13257. https:\/\/doi.org\/10.1038\/ncomms13257 (2016).","journal-title":"Nat. Commun."},{"key":"1387_CR112","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fimmu.2020.00170","volume":"11","author":"CA James","year":"2020","unstructured":"James, C. A. & Seshadri, C. T Cell responses to mycobacterial glycolipids: on the spectrum of \u201cinnateness. Front. Immunol. 11, 170 (2020).","journal-title":"Front. Immunol."},{"key":"1387_CR113","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","volume":"167","author":"LL Lu","year":"2016","unstructured":"Lu, L. L. et al. A functional role for antibodies in tuberculosis. Cell 167, 433\u2013443 e414 (2016).","journal-title":"Cell"},{"key":"1387_CR114","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1172\/JCI128459","volume":"130","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Capsular glycan recognition provides antibody-mediated immunity against tuberculosis. J. Clin. Invest. 130, 1808\u20131822 (2020).","journal-title":"J. Clin. Invest."},{"key":"1387_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104897","volume":"99","author":"E Ishida","year":"2024","unstructured":"Ishida, E. et al. Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates. EBioMedicine 99, 104897. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104897 (2024).","journal-title":"EBioMedicine"},{"key":"1387_CR116","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.07.617070","author":"PS Grace","year":"2024","unstructured":"Grace, P. S. et al. Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction. bioRxiv https:\/\/doi.org\/10.1101\/2024.10.07.617070 (2024).","journal-title":"bioRxiv"},{"key":"1387_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-276","volume":"13","author":"WA Keitel","year":"2013","unstructured":"Keitel, W. A. et al. Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen. BMC Infect. Dis. 13, 276 (2013).","journal-title":"BMC Infect. Dis."},{"key":"1387_CR118","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/s41564-024-01777-9","volume":"9","author":"EB Irvine","year":"2024","unstructured":"Irvine, E. B. et al. Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis. Nat. Microbiol. 9, 2369\u20132382 (2024).","journal-title":"Nat. Microbiol."},{"key":"1387_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112504","volume":"28","author":"KE van Meijgaarden","year":"2025","unstructured":"van Meijgaarden, K. E. et al. Sera contributing to mycobacterial growth restriction in vitro display enhanced Fc-mediated phagocytosis. iScience 28, 112504. https:\/\/doi.org\/10.1016\/j.isci.2025.112504 (2025).","journal-title":"iScience"},{"key":"1387_CR120","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. JCI insight 8 https:\/\/doi.org\/10.1172\/jci.insight.167960 (2023).","DOI":"10.1172\/jci.insight.167960"},{"key":"1387_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114426","volume":"43","author":"CY Tsai","year":"2024","unstructured":"Tsai, C. Y. et al. Splenic marginal zone B cells restrict Mycobacterium tuberculosis infection by shaping the cytokine pattern and cell-mediated immunity. Cell Rep. 43, 114426. https:\/\/doi.org\/10.1016\/j.celrep.2024.114426 (2024).","journal-title":"Cell Rep."},{"key":"1387_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107610","volume":"150","author":"S Banoo","year":"2024","unstructured":"Banoo, S., Yadav, Y., Tyagi, R., Manna, A. & Sagar, R. Recent efforts in the development of glycoconjugate vaccine and available treatment for tuberculosis. Bioorg. Chem. 150, 107610. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107610 (2024).","journal-title":"Bioorg. Chem."},{"key":"1387_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127912","volume":"68","author":"S Miranda-Hernandez","year":"2025","unstructured":"Miranda-Hernandez, S., Sathkumara, H. D., Zhao, G., Schofield, L. & Kupz, A. Co-administration of a synthetic saccharide conjugate vaccine with BCG provides synergistic protection against murine tuberculosis. Vaccine 68, 127912. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127912 (2025).","journal-title":"Vaccine"},{"key":"1387_CR124","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1021\/jacs.8b00669","volume":"140","author":"L Wang","year":"2018","unstructured":"Wang, L., Overkleeft, H. S., van der Marel, G. A. & Codee, J. D. C. Reagent controlled stereoselective synthesis of alpha-glucans. J. Am. Chem. Soc. 140, 4632\u20134638 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"1387_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00834-y","volume":"9","author":"S Chugh","year":"2024","unstructured":"Chugh, S., Bahal, R. K., Dhiman, R. & Singh, R. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development. NPJ Vaccines 9, 57 (2024).","journal-title":"NPJ Vaccines"},{"key":"1387_CR126","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tube.2013.11.003","volume":"94","author":"H McShane","year":"2014","unstructured":"McShane, H. & Williams, A. A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis (Edinb.) 94, 105\u2013110 (2014).","journal-title":"Tuberculosis (Edinb.)"},{"key":"1387_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1609136","volume":"16","author":"L Del Pozo-Ramos","year":"2025","unstructured":"Del Pozo-Ramos, L. & Kupz, A. A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models. Front. Immunol. 16, 1609136. https:\/\/doi.org\/10.3389\/fimmu.2025.1609136 (2025).","journal-title":"Front. Immunol."},{"key":"1387_CR128","doi-asserted-by":"publisher","first-page":"e1011825","DOI":"10.1371\/journal.ppat.1011825","volume":"19","author":"CR Plumlee","year":"2023","unstructured":"Plumlee, C. R. et al. Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model. PLoS Pathog. 19, e1011825 (2023).","journal-title":"PLoS Pathog."},{"key":"1387_CR129","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/infdis\/jiz020","volume":"219","author":"P Elkington","year":"2019","unstructured":"Elkington, P. et al. In vitro granuloma models of tuberculosis: potential and challenges. J. Infect. Dis. 219, 1858\u20131866 (2019).","journal-title":"J. Infect. Dis."},{"key":"1387_CR130","doi-asserted-by":"publisher","unstructured":"Morgun, E. et al. Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells. eLife 12 https:\/\/doi.org\/10.7554\/eLife.87431 (2023).","DOI":"10.7554\/eLife.87431"},{"key":"1387_CR131","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.crstbi.2021.06.001","volume":"3","author":"A Gijsbers","year":"2021","unstructured":"Gijsbers, A. et al. Priming mycobacterial ESX-secreted protein B to form a channel-like structure. Curr. Res Struct. Biol. 3, 153\u2013164 (2021).","journal-title":"Curr. Res Struct. Biol."},{"key":"1387_CR132","doi-asserted-by":"publisher","unstructured":"Ramon-Luing, L. A., Palacios, Y., Ruiz, A., Tellez-Navarrete, N. A. & Chavez-Galan, L. Virulence factors of Mycobacterium tuberculosis as modulators of cell death mechanisms. Pathogens 12 https:\/\/doi.org\/10.3390\/pathogens12060839 (2023).","DOI":"10.3390\/pathogens12060839"},{"key":"1387_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107425","volume":"26","author":"E Jalbert","year":"2023","unstructured":"Jalbert, E. et al. Comparative immune responses to Mycobacterium tuberculosis in people with latent infection or sterilizing protection. iScience 26, 107425. https:\/\/doi.org\/10.1016\/j.isci.2023.107425 (2023).","journal-title":"iScience"},{"key":"1387_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01110-3","volume":"10","author":"MJ Felgueres","year":"2025","unstructured":"Felgueres, M. J. et al. Cytolytic gammadelta T-cells and IFNgamma-producing CD4-lymphocytes characterise the early response to MTBVAC tuberculosis vaccine. NPJ Vaccines 10, 58 (2025).","journal-title":"NPJ Vaccines"},{"key":"1387_CR135","doi-asserted-by":"publisher","unstructured":"Tkachuk, A. P. et al. Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: a phase II, multi-center, double-blind, randomized, placebo-controlled study. Vaccines 8 https:\/\/doi.org\/10.3390\/vaccines8040652 (2020).","DOI":"10.3390\/vaccines8040652"},{"key":"1387_CR136","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S1473-3099(22)00222-5","volume":"22","author":"MF Cotton","year":"2022","unstructured":"Cotton, M. F. et al. Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial. Lancet Infect. Dis. 22, 1472\u20131483 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1387_CR137","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1074\/jbc.M112.415679","volume":"288","author":"CJ Kuo","year":"2013","unstructured":"Kuo, C. J., Ptak, C. P., Hsieh, C. L., Akey, B. L. & Chang, Y. F. Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex. J. Biol. Chem. 288, 3886\u20133896 (2013).","journal-title":"J. Biol. Chem."},{"key":"1387_CR138","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jmii.2014.03.005","volume":"48","author":"JB Lu","year":"2015","unstructured":"Lu, J. B. et al. Recombinant tuberculosis vaccine AEC\/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection. J. Microbiol. Immunol. Infect. 48, 597\u2013603 (2015).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"1387_CR139","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s40121-023-00806-0","volume":"12","author":"YH Choi","year":"2023","unstructured":"Choi, Y. H. et al. Safety and immunogenicity of the ID93 + GLA-SE tuberculosis vaccine in BCG-vaccinated healthy adults: a randomized, double-blind, placebo-controlled phase 2 trial. Infect. Dis. Ther. 12, 1605\u20131624 (2023).","journal-title":"Infect. Dis. Ther."},{"key":"1387_CR140","doi-asserted-by":"publisher","unstructured":"Vasilyev, K. et al. Enhancement of the local CD8(+) T-cellular immune response to Mycobacterium tuberculosis in BCG-primed mice after intranasal administration of influenza vector vaccine carrying TB10.4 and HspX antigens. Vaccines 9 https:\/\/doi.org\/10.3390\/vaccines9111273 (2021).","DOI":"10.3390\/vaccines9111273"},{"key":"1387_CR141","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1016\/j.vaccine.2020.09.055","volume":"38","author":"P Munseri","year":"2020","unstructured":"Munseri, P. et al. DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: a randomized controlled, double-blind phase 2b trial. Vaccine 38, 7239\u20137245 (2020).","journal-title":"Vaccine"},{"key":"1387_CR142","doi-asserted-by":"publisher","first-page":"e0175215","DOI":"10.1371\/journal.pone.0175215","volume":"12","author":"CF von Reyn","year":"2017","unstructured":"von Reyn, C. F. et al. Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: a randomized, controlled trial of DAR-901. PLoS One 12, e0175215 (2017).","journal-title":"PLoS One"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01387-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01387-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01387-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:03:53Z","timestamp":1780963433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01387-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01387-y","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}